Phesgo
NDC 50242-260, pertuzumab, trastuzumab, and hyaluronidase-zzxf, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-260
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761170
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PERTUZUMAB600 mg/10mL
- TRASTUZUMAB600 mg/10mL
- HYALURONIDASE (HUMAN RECOMBINANT)20000 U/10mL
Pharmacologic classes
Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; HER2/Neu/cerbB2 Antagonists [MoA]; HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]; HER2/neu Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-260-01 | 50242026001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
| 50242-260-86 | 50242026086 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-86) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/27dd5e6b-72cd-458d-a015-cf4dab5800daMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-260
Use it
Look up 50242-260 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-260. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.